Global Atrial Fibrillation Market (Treatment Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

Atrial fibrillation (AF) is a type of arrhythmia which is characterized by poor blood flow in the body due to an irregular and rapid heart rate. The geriatric population is generally more susceptible to this disease. Promising results in clinical trials for combination treatment for atrial fibrillation boosts the growth of the global atrial fibrillation market. C.R. Bard, Inc., Becton Dickinson & company, Baxter International, Inc., St. Jude Medical, Inc. Bristol-Myers Squibb Corporation, Johnson & Johnson, Sanofi, CardiofFocus, and Endoscopic Technologies are some key players in the market

The atrial fibrillation market is segmented into treatment types and geography. On the basis of treatment types, the atrial fibrillation market is segmented into Pharmacological Treatment and Non-Pharmacological Treatment. The pharmacological treatment market is further segmented into anti-arrhythmic drugs and anti-coagulant drugs. The non-pharmacological treatment market is segmented into Catheter Ablation, Maze Surgery and Electric Cardioversion. Catheter ablation is segmented into radiofrequency based, cryoablation based, high intensity focused ultrasound based, microwave based and laser based catheter ablation procedures. Geographically, the atrial fibrillation market is segmented into North America, Europe, Asia-Pacific and LAMEA. 

KEY BENEFITS

• The report throws light on the dominant current trends. Based on the understanding of trends, revenues are forecast from 2013-2020.
• Market intelligence for key developmental strategies adopted by top companies is explained with impact analysis.
• Analysis of trends in various regions would help companies to plan their strategies depending on the region.
• Drivers and opportunities are evaluated to highlight the top factors responsible for market growth.
• Porter’s Five Forces analysis provides an insight into market dynamics and industry competition.

KEY MARKET SEGMENTS

MARKET BY TREATMENT TYPE

• Pharmacological Treatment 
  • Anti-arrhythmic drugs
  • Anti-coagulant drugs
• Non-pharmacological Treatment 
  • Catheter ablation
    • Radiofrequency based
    • Cryoablation based 
    • High Intensity focused ultrasound based
    • Microwave based
    • Laser based
  • Maze surgery  
  • Electric Cardioversion

MARKET BY GEOGRAPHY

• North America
• Europe
• Asia-Pacific
• LAMEA